BlackRock’s Inovio Pharmaceuticals INO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$1.09M Sell
537,628
-1,780,852
-77% -$3.62M ﹤0.01% 4153
2025
Q1
$3.78M Buy
2,318,480
+409,969
+21% +$668K ﹤0.01% 3707
2024
Q4
$3.49M Buy
1,908,511
+22,916
+1% +$41.9K ﹤0.01% 3811
2024
Q3
$10.9M Buy
1,885,595
+179,175
+11% +$1.04M ﹤0.01% 3315
2024
Q2
$13.8M Buy
1,706,420
+1,366,734
+402% +$11M ﹤0.01% 3146
2024
Q1
$4.71M Buy
339,686
+11,972
+4% +$166K ﹤0.01% 3638
2023
Q4
$2.01M Sell
327,714
-165,548
-34% -$1.01M ﹤0.01% 3965
2023
Q3
$2.3M Sell
493,262
-13,957
-3% -$65.2K ﹤0.01% 3883
2023
Q2
$2.72M Sell
507,219
-1,427,853
-74% -$7.65M ﹤0.01% 3848
2023
Q1
$19M Sell
1,935,072
-5,271
-0.3% -$51.9K ﹤0.01% 2944
2022
Q4
$36.3M Buy
1,940,343
+144,950
+8% +$2.71M ﹤0.01% 2649
2022
Q3
$37.2M Buy
1,795,393
+134,926
+8% +$2.79M ﹤0.01% 2644
2022
Q2
$34.5M Buy
1,660,467
+156,559
+10% +$3.25M ﹤0.01% 2703
2022
Q1
$64.8M Sell
1,503,908
-16,502
-1% -$711K ﹤0.01% 2390
2021
Q4
$91M Sell
1,520,410
-10,394
-0.7% -$622K ﹤0.01% 2255
2021
Q3
$132M Buy
1,530,804
+16,496
+1% +$1.42M ﹤0.01% 2012
2021
Q2
$168M Buy
1,514,308
+54,720
+4% +$6.09M ﹤0.01% 1890
2021
Q1
$163M Buy
1,459,588
+272,676
+23% +$30.4M ﹤0.01% 1855
2020
Q4
$126M Buy
1,186,912
+44,230
+4% +$4.7M ﹤0.01% 1911
2020
Q3
$159M Sell
1,142,682
-5,958
-0.5% -$829K 0.01% 1563
2020
Q2
$371M Buy
1,148,640
+429,716
+60% +$139M 0.01% 893
2020
Q1
$64.2M Buy
718,924
+82,707
+13% +$7.38M ﹤0.01% 1906
2019
Q4
$25.2M Sell
636,217
-14,982
-2% -$593K ﹤0.01% 2718
2019
Q3
$16M Buy
651,199
+8,797
+1% +$216K ﹤0.01% 2916
2019
Q2
$22.7M Buy
642,402
+27,946
+5% +$986K ﹤0.01% 2757
2019
Q1
$27.5M Buy
614,456
+10,129
+2% +$453K ﹤0.01% 2577
2018
Q4
$29M Buy
604,327
+24,382
+4% +$1.17M ﹤0.01% 2520
2018
Q3
$38.7M Buy
579,945
+9,500
+2% +$634K ﹤0.01% 2498
2018
Q2
$26.8M Buy
570,445
+29,676
+5% +$1.4M ﹤0.01% 2679
2018
Q1
$30.6M Sell
540,769
-11,523
-2% -$651K ﹤0.01% 2525
2017
Q4
$27.4M Sell
552,292
-4,963
-0.9% -$246K ﹤0.01% 2598
2017
Q3
$42.4M Buy
557,255
+101,479
+22% +$7.72M ﹤0.01% 2361
2017
Q2
$42.9M Buy
455,776
+12,776
+3% +$1.2M ﹤0.01% 2333
2017
Q1
$35.2M Buy
443,000
+442,451
+80,592% +$35.1M ﹤0.01% 2421
2016
Q4
$46K Sell
549
-77
-12% -$6.45K ﹤0.01% 2911
2016
Q3
$71K Buy
626
+65
+12% +$7.37K ﹤0.01% 2732
2016
Q2
$62K Buy
561
+159
+40% +$17.6K ﹤0.01% 2787
2016
Q1
$42K Sell
402
-100
-20% -$10.4K ﹤0.01% 2401
2015
Q4
$41K Buy
502
+394
+365% +$32.2K ﹤0.01% 2141
2015
Q3
$8K Hold
108
﹤0.01% 2800
2015
Q2
$11K Sell
108
-12
-10% -$1.22K ﹤0.01% 2673
2015
Q1
$12K Hold
120
﹤0.01% 2596
2014
Q4
$13K Hold
120
﹤0.01% 2568
2014
Q3
$14K Hold
120
﹤0.01% 2488
2014
Q2
$16K Buy
120
+117
+3,900% +$15.6K ﹤0.01% 2454
2014
Q1
$0 Buy
+3
New ﹤0.01% 3110